RESUMO
Essential oils (EOs) of three Iranian cultivated Nepeta species were investigated. The oils were obtained by hydrodistillation of air-dried plant materials at full flowering stage and analyzed by gas chromatography (GC) and gas chromatography coupled to mass spectroscopy (GC/MS). In total, 89 compounds were detected. In over 2 years, a number of constituents were identified in the EO of Nepeta binaloudensis first and second years (26 and 37, respectively), Nepeta cataria (25 and 32, respectively), and Nepeta assurgens (45 and 50, respectively). In the oils of N. binaloudensis, 4a-α,7-α,7a-α-nepetalactone (NL) 59.7% and 1,8-cineole (19.6%) during the first and second years, respectively, were the main constituents. The main components of N. cataria were 4a-α,7-α,7a-ß-NL (72.8%) and 4a-α,7-ß,7a-α-NL (73.9%) during the first and second years, respectively, and 4a-α,7-α,7a-α-NL (55.5%) and 1,8-cineole (24.1%) during the first and second years, respectively, were the main constituents of N. assurgens. The results showed that NLs isomers and 1,8-cineole were the main components of the oils of three cultivated Nepeta species.
Assuntos
Nepeta/crescimento & desenvolvimento , Óleos Voláteis/química , Óleos Voláteis/isolamento & purificação , Destilação , Cromatografia Gasosa-Espectrometria de Massas , Irã (Geográfico) , Nepeta/química , Óleos de Plantas/química , Óleos de Plantas/isolamento & purificaçãoRESUMO
Hydrodistallation of the aerial parts of Nepeta transcaucasica Grossh. (Lamiaceae), collected in Agri, Dogubayazit Province, afforded an essential oil that was characterized by GC and GC/MS analyses. Twenty-seven compounds, representing 97.69% of the total oil composition, were identified, and 4aα,7α,7aß-nepetalactone (1; 39%), 4aα,7α,7aα-nepetalactone (2; 28%), and germacrene D (3; 15%) constituted the major components. The anticandidal effects of the oil were evaluated against seven Candida strains by using the broth microdilution method. The oil showed good inhibitory effects against C. glabrata and C. tropicalis at minimal inhibitory concentrations (MICs) of 0.09 and 0.375 mg/ml, respectively.